All articles tagged with #supply shortages
Originally Published 13 days ago — by Yahoo Finance
Silver's price surged above $80, reaching a record high due to Chinese speculative demand, but then sharply retreated over 6% after hitting $84, amid concerns over supply shortages and market volatility, with measures being taken to curb speculation.
Originally Published 1 year ago — by ABC News
Chick-fil-A is abandoning its "no antibiotics ever" pledge for chicken due to projected supply shortages, shifting to a "no antibiotics important to human medicine" policy. The fast-food chain emphasizes its commitment to high-quality chicken through selectivity, animal wellbeing standards, and evolving its approach. This decision comes amid increasing outbreaks of bird flu at U.S. chicken farms, leading to reduced supplies and higher prices.
Originally Published 1 year ago — by Fox Business
Cocoa prices have hit a record high due to crop damage in West Africa, leading to a surge in chocolate prices just in time for Valentine's Day. The ongoing shortages are affecting chocolate manufacturers, who are passing the price hikes on to customers. This has led to concerns about prolonged supply shortages and a slowdown in demand for chocolate products from cash-conscious customers. The surge in prices is also impacting major chocolate companies like Hershey and Mondelez, with expectations of limited earnings growth.
Originally Published 1 year ago — by CNBC
Demand for weight loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound is outstripping supply, leading to intermittent shortages and limited availability. Both companies are making efforts to increase production capacity, with Novo Nordisk doubling its supply of lower-dose Wegovy and Eli Lilly doubling production capacity for its incretin drugs. Novo Nordisk's parent company's acquisition of Catalent and investments in new production facilities, along with Eli Lilly's plans to launch drugs in alternative delivery devices and develop oral weight loss drugs, aim to address supply constraints in the future.
Originally Published 2 years ago — by NPR
The recent approval of the RSV monoclonal antibody Nirsevimab has raised hopes for protecting infants from RSV, a leading cause of hospitalization and death among babies. However, the limited supply and high cost of Nirsevimab, along with bureaucratic obstacles in Medicaid's vaccine distribution system, have hindered its availability. Demand for the antibody has already outstripped supply, prompting the CDC to issue interim guidance on prioritizing high-risk infants. Additionally, the rollout of the RSV vaccine from Pfizer has faced challenges due to concerns about potential preterm births. The lack of clarity on where and when newborns should receive the shot has left many parents confused. Health systems are hoping to keep infants out of the hospital this winter, as last year's RSV surge overwhelmed hospitals and prompted public health emergencies.
Originally Published 2 years ago — by New York Post
California's Independent System Operator (ISO) is closely monitoring the power grid as heat waves sweep across the state, warning of potential supply shortages and increased electricity demand. While energy supplies are currently sufficient, ISO may issue emergency notifications and urge consumers to reduce power usage if conditions worsen. The northern interior and desert Southwest regions are expected to experience temperatures well above average for mid-August, further straining the grid.
Originally Published 2 years ago — by New York Post
The backlash against Bud Light's promo with transgender influencer Dylan Mulvaney has put rival beers in high demand, leading to potential supply shortages for Coors Light and Miller Lite during the Memorial Day weekend. Beer Business Daily editor Harry Schuhmacher believes that the newfound demand for light lagers not owned by Anheuser-Busch could result in a trickle-down effect on the industry. While Anheuser-Busch has begun buying back unsold, expired beer from distributors, distributors who rely on Americans purchasing Bud Light will continue to suffer. However, Schuhmacher expects the backlash will eventually die down, and Bud Light will stay on top despite long-lasting scars.